This inventor holds 2 USPTO granted patents. Top assignee: Wake Forest University. Active years: 2001-2004.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2001-2004
Title: David M. Herrington: Inventor in Medical and Genetic Research.
Introduction
David M. Herrington is an inventor associated with Winston-Salem, North Carolina, and Wake Forest University. His patent work spans genetic markers related to hormone replacement therapy and ultrasound-based tissue characterization. His portfolio includes 2 patents.
Latest Patents
- Genetic polymorphisms of estrogen receptor alpha associated with favorable response to hormone replacement therapy. This invention describes screening a subject for estrogen receptor alpha polymorphisms that may indicate a greater likelihood of a favorable response to estrogen replacement therapy, including potential benefits related to cardiovascular health, heart disease, or HDL levels.
- Ultrasound apparatus and method for tissue characterization. This invention concerns ultrasound devices and methods for identifying and characterizing tissues, transitions between tissues, and tissue structures.
Career Highlights
Herrington’s listed inventions reflect work at the intersection of medical technology and health research. One focuses on genetic variation and treatment response, while the other addresses ultrasound methods for examining tissue.
Collaborations
Herrington’s listed coworkers include Gregory A. Hawkins and Deborah Meyers. His company affiliation is Wake Forest University.
Conclusion
David M. Herrington’s two listed patents address distinct approaches to medical research, combining genetic screening for treatment response with ultrasound-based tissue characterization.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile